We hypothesize that the supplementation of VD3 in PCOS rats affects the transcript and protein levels of RARRES2 and ADIPOQ, as well as its receptors in the uterus and plasma levels of both adipokines. This evidence concerns the gene ADIPOQ and polycystic ovary syndrome.